1. Kraljevic S, Stambrook PJ, Pavelic K. Accelerating drug discovery. EMBO Reports. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1299137/pdf/5-7400236.pdf. Published September 2004. Accessed November 9, 2015.
2. US Food and Drug Administration. CDER 21st century review process. http://www.fda.gov/forpatients/approvals/fast/ucm20041766.htm. Accessed August 29, 2015.
3. US Food and Drug Administration. Fast Track, Breakthrough Therapy, Accelerated Approval, Priority Review. http://www.fda.gov/forpatients/approvals/fast/ucm20041766.htm. Published September 18, 2014. Accessed August 29, 2015.
4. US Food and Drug Administration. sDeveloping products for rare diseases and conditions. http://www.fda.gov/ForIndustry/DevelopingProductsforRareDiseasesConditions/ucm2005525.htm. Published August 17, 2015. Accessed August 31, 2015.
5. US Food and Drug Administration. Novel new drugs 2014 summary. http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/DrugInnovation/UCM430299.pdf. Published January 2015. Accessed August 31, 2015.